Search results

  1. Eddie

    Trial Report The Head-Up Tilt Table Test as a Measure of Autonomic Functioning among Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, 2024, Jason

    This video seems to be a pretty good summary of the literature already out there. These are the kind of result the NIH should have tested in their study. It also seems like the controls in a majority of these studies had far lower orthostatic symptom burden than the NIH found.
  2. Eddie

    Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome, 2024, Walitt et al

    This all begs the question: what should we ask the NIH to follow up on? And if there is nothing in the paper that warrants follow up study, what is the next thing they should focus on to find clues?
  3. Eddie

    Trial Report The Head-Up Tilt Table Test as a Measure of Autonomic Functioning among Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, 2024, Jason

    Thanks for taking the time to respond EndME. I think your points are very reasonable and help clarify the issue for me. As always so many questions have yet to be answered. In this case, I would not be surprised if the only reason the tilt table is used for "POTS" is because it is an abnormality...
  4. Eddie

    Trial Report The Head-Up Tilt Table Test as a Measure of Autonomic Functioning among Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, 2024, Jason

    I am genuinely curious why is a control group useful in such a study? To me it seems like the purpose of this paper was to figure out what percentage of pwME also meet the criteria for POTS. If a number of controls had a positive tilt table test all that seems to say is that those people would...
  5. Eddie

    Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome, 2024, Walitt et al

    That seems to be correct. They don't tell us what % of people had excessive orthostatic tachycardia at 40 minuets, and don't even specifically tell us what they mean by excessive orthostatic tachycardia. Its not clear what the heart rate response was as there are no references to heart rate at...
  6. Eddie

    Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome, 2024, Walitt et al

    If someone naturally has to do things to prevent themselves from fainting in everyday life, I would argue they should not be a control in a ME/CFS or POTS study. Perhaps it is a function of my youth, but I have met very few people in the general population (far less than the 40% here) who have...
  7. Eddie

    Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome, 2024, Walitt et al

    Interesting, I assumed that a healthy person couldn't have such an increase in heart rate. It is also possible that these aren't false positives but instead these people really do have orthostatic problems that they aren't particularly aware of or have less severe symptoms. Either way, it seems...
  8. Eddie

    Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome, 2024, Walitt et al

    This seemed bizarre to me so I decided to do some digging. They don't include any of the tilt table data in the Supplementary Data and except in file #22 where they list it as a negative finding. However in a short section on page 49 of the supplementary data they add They list this paper...
  9. Eddie

    Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome, 2024, Walitt et al

    What do you mean by finding any differences? What are you comparing between the people did 1 CPET vs 2? The people who did the 1 day would still have PEM you just wouldn't pick it up on the 2nd CPET assuming a difference really does occur.
  10. Eddie

    Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome, 2024, Walitt et al

    Its not quite that, its more like we aren't going to try and objectively measure PEM (for the reasons given) but instead going to measure lots of things to see if we can find something that could be causing PEM. Of course they failed to make any real progress towards that goal. Because they...
  11. Eddie

    Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome, 2024, Walitt et al

    Upon further reflection, I think my biggest gripe with the paper (besides the small sample size and BPS influences) is it took so long to come out that much of what was done seems outdated now. The CPET work is outdated by Systrom's invasive CPET test and many of the two day CPET's that have...
  12. Eddie

    Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome, 2024, Walitt et al

    This may be an unpopular opinion but I understand why they used a 1-day CPET. It makes sense that by taking measurements when PEM is induced on the 2nd day, they were trying to find the cause of the lower 2nd day CPET results, not validate them. I think it is relatively well known that the 2nd...
  13. Eddie

    Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome, 2024, Walitt et al

    Um isn't that like 4 times the legal limit for driving?
  14. Eddie

    Blood–brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment, 2024, Greene et al

    I have been trying to figure out how DCE-MRI works and what is shows regarding BBB disfunction. They inject a contrast agent, in this case gadobenate dimeglumine, which can pass through vascular endothelium into the extracellular spaces of most tissues. However, in the brain the BBB prevents...
  15. Eddie

    Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome, 2024, Walitt et al

    The vast majority of the people were not picked because they had an onset greater than 5 years ago, had no record of infection or had other diagnoses. I don't think they weren't picked because of CCC criteria. 9 of the study participants fulfilled the CCC and for those that did not, 3 were...
  16. Eddie

    Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome, 2024, Walitt et al

    Its not so much that my brain is somehow preventing me from pushing through. I can push through but I understand that comes at a cost. I generally don't push through just because the costs exceed the benefits. When I was a rower I pushed through all the time because the costs weren't very high...
  17. Eddie

    Grip test results and brain imaging in the NIH study: Deep phenotyping of PI-ME/CFS, 2024, Walitt et al

    This difference in performance correlated with decreased activity of the right temporal-parietal junction, a part of the brain that is focused on determining “mismatch” between willed action and resultant movement. Mismatch relates to the degree of agency, the sense of control of the movement...
  18. Eddie

    Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome, 2024, Walitt et al

    Some other information on recruitment that I found in Supplementary Data 2. There were 484 people that applied for the study. Of those, 137 were found to have other diagnosis during the initial screening. Not too sure while you'd apply for a ME/CFS study if you knew you had an autoimmune...
  19. Eddie

    Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome, 2024, Walitt et al

    Does anyone have any thoughts on why none of the participants had pots? Is this a selection problem or are pots and ME just unrelated?? I really don't know what to make of this
Back
Top Bottom